4-((3,4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-oxopentanoic acid,
CR 1409,
CR-1409,
lorglumide,
Lorglumide sodium,
Lorglumide sodium salt,
CR 1409,
1021868-76-7,
NCGC00016161-03,
DSSTox_CID_25228,
DSSTox_RID_80765,
DSSTox_GSID_45228,
CAS-1021868-76-7,
C22H31Cl2N2NaO4,
MLS000859951,
SPECTRUM2300261,
CHEMBL1255589,
DTXSID8045228,
CTK8G0634,
HY-B1439B,
HMS1570H12,
HMS2097H12,
HMS2231K15,
HMS3262C04,
HMS3372O19,
HMS3714H12,
Tox21_110312,
Tox21_500731,
BDBM50005104,
Tox21_110312_1,
CCG-214025,
LP00731,
NCGC00016161-02,
NCGC00094077-01,
NCGC00094077-02,
NCGC00162232-06,
NCGC00261416-01,
SMR000326810,
CS-0046338,
EU-0100731,
X6892,
potassium 4-[(3,4-dichlorophenyl)formamido]-4-(dipentylcarbamoyl)butanoate,
sodium 4-[(3,4-dichlorophenyl)formamido]-4-(dipentylcarbamoyl)butanoate,
(+/-)-4-([3,4-DICHLOROBENZOYL]AMINO)-5-(DIPENTYLAMINO)-5-OXOPENTANOIC ACID SODIUM,
( inverted exclamation markA)-4-[(3,4-Dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid sodium salt,
Lorglumide,
Lorglumida,
Lorglumidum,
Lorglumide [INN],
Lorglumidum [Latin],
Lorglumida [Spanish],
UNII-LAD1UQ73BE,
C22H32Cl2N2O4,
CCRIS 6857,
C22-H32-Cl2-N2-O4,
CID11957595,
NCGC00016161-01,
L-109,
97964-56-2,
D,L-4-(3,4-Dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pentanoic acid,